Intrinsic value of Rapport Therapeutics, Inc. Common Stock (RAPP)
Live fair value data for Rapport Therapeutics, Inc. Common Stock (RAPP) is currently unavailable. Please check again shortly.
Current Price: $107.00
Valuation: Undervalued
Confidence: 9.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Rapport Therapeutics, Inc. Common Stock (RAPP) undervalued or overvalued?
Based on the current model output, Rapport Therapeutics, Inc. Common Stock appears to be undervalued with a upside of 55.00%.
Fair value vs market price — Rapport Therapeutics, Inc. Common Stock (RAPP)
Unlock premium access to view the live fair value comparison against current market price for RAPP.
Frequently Asked Questions - RAPP
How is RAPP intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for RAPP.
Is RAPP undervalued or overvalued right now?
RAPP is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for RAPP: open their intrinsic value pages.